SelectScience
Join Free
Product NewsDrug Discovery & Development

Advancing the future of LNP and RNA characterization

Waters
24 Sept 2026

Innovation in RNA-based therapeutics depends on scientific collaboration, advanced analytical technologies, and a deeper understanding of complex drug delivery systems. Hear from Jérémie Parot at SINTEF as he shares how their partnership with Waters has helped simplify and streamline the analysis of multiple critical quality attributes (CQAs) of lipid nanoparticles (LNPs) and RNA through user-friendly mass spectrometry, light scattering technology, and automation. Watch the full interview to discover how this collaboration is advancing analytical workflows and helping shape the future of LNP and RNA characterization.

About the company

Waters logo

Waters

Waters Corporation, the premium brand in the analytical instruments industry since 1958, creates business advantages for laboratory-dependent organizations by delivering practical and sustainable scientific innovation to enable significant advancements in such areas as: healthcare delivery, environmental management, food safety, chemical materials analysis, and water quality worldwide. Waters helps customers make profound discoveries, optimize laboratory operations, deliver product performance, and ensure regulatory compliance by providing a connected portfolio of separations and analytical science, mass spectrometry, laboratory informatics, as well as thermal analysis products.

4.5/5.0
|1723 Reviews
Company ProfileCompany Website

What does this video cover?

Company Logo

Topics covered in this video

  • How does the SINTEF-Waters partnership advance RNA-based therapeutics?
  • How are lipid nanoparticle critical quality attributes analyzed?
  • Which technologies streamline LNP and RNA characterization workflows?
  • How does automation simplify mass spectrometry and light scattering analysis?
  • What does Jérémie Parot reveal about future LNP analytical workflows?

Other videos from Waters

Links

WatersCompany website

Tags

Mass SpectrometryMass spectrometry (MS) is a powerful analytical technique used to identify and quantify molecules based on the mass-to-charge ratio of gas-phase ions. It provides detailed information about the structure, composition, and properties of compounds and is widely used across fields such as environmental monitoring, materials science, drug discovery and development, food and beverage testing, and wider chemical research. Key MS techniques include tandem mass spectrometry (MS/MS), liquid chromatography–mass spectrometry (LS-MS) and inductively coupled plasma (ICP-MS). Choosing from these wide range of techniques and technologies can be a daunting task, so keep up to date with scientific applications, performance expectations, and customer reviews here all in one place. Visit our product directory to receive quotes direct from the manufacturer. Multi Angle Light ScatteringRNARNA is a nucleic acid that plays a key role in gene expression and protein synthesis. It serves as a messenger between DNA and ribosomes, carrying genetic instructions to produce proteins. Advances in RNA-based therapies, such as mRNA vaccines and gene editing, have revolutionized treatment strategies for genetic disorders and infectious diseases. Explore RNA research tools and therapies in our peer-reviewed product directory; compare products, check customer reviews, and get pricing directly from manufacturers.Solid Lipid Nanoparticles

Frequently asked questions

Show frequently asked questions

How are SINTEF and Waters advancing LNP and RNA characterization?

Their scientific collaboration simplifies and streamlines analytical workflows for multiple critical quality attributes (CQAs) of lipid nanoparticles (LNPs) and RNA.

Which analytical technologies support RNA and lipid nanoparticle analysis?

SINTEF uses user-friendly mass spectrometry, light scattering technology, and automation through its partnership with Waters to analyze LNP and RNA quality attributes.

Why are advanced analytical workflows important for RNA-based therapeutics?

Advanced workflows provide a deeper understanding of complex drug delivery systems and support the characterization of RNA and lipid nanoparticles, helping shape the future of RNA-based therapeutics.

Related videos